Abstract 2621: Growth hormone receptor antagonist sensitizes melanoma and hepatocarcinoma to drug treatments via downregulation of ABC transporters in vivo

MLA

Yanrong Qian, et al. “Abstract 2621: Growth Hormone Receptor Antagonist Sensitizes Melanoma and Hepatocarcinoma to Drug Treatments via Downregulation of ABC Transporters in Vivo.” Cancer Research, vol. 82, June 2022, p. 2621. EBSCOhost, https://doi.org/10.1158/1538-7445.am2022-2621.

APA

Yanrong Qian, Reetobrata Basu, Samuel Mathes, Prateek Kulkarni, Emily Davis, Darlene Berryman, Edward List, Silvana Duran, & John J. Kopchick. (2022). Abstract 2621: Growth hormone receptor antagonist sensitizes melanoma and hepatocarcinoma to drug treatments via downregulation of ABC transporters in vivo. Cancer Research, 82, 2621. https://doi.org/10.1158/1538-7445.am2022-2621

Chicago

Yanrong Qian, Reetobrata Basu, Samuel Mathes, Prateek Kulkarni, Emily Davis, Darlene Berryman, Edward List, Silvana Duran, and John J. Kopchick. 2022. “Abstract 2621: Growth Hormone Receptor Antagonist Sensitizes Melanoma and Hepatocarcinoma to Drug Treatments via Downregulation of ABC Transporters in Vivo.” Cancer Research 82 (June): 2621. doi:10.1158/1538-7445.am2022-2621.